亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Abstract 3972: Ex vivo profiling of PD-1 blockade using organotypic tumor spheroids

离体 肿瘤微环境 免疫系统 癌症研究 免疫疗法 细胞因子 趋化因子 免疫检查点 封锁 癌症免疫疗法 CD8型 生物 免疫学 体内 医学 受体 内科学 生物技术
作者
David A. Barbie,Russell W. Jenkins,Kwok‐Kin Wong
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:77 (13_Supplement): 3972-3972
标识
DOI:10.1158/1538-7445.am2017-3972
摘要

Abstract Despite the impressive activity of PD-1/PD-L1 immune checkpoint blockade in melanoma, lung, and other cancers, the majority of patients are intrinsically resistant to this therapy. Furthermore, despite years of effort few robust biomarkers of response exist, and tumor PD-L1 expression and mutational load are only partially predictive of activity. Nearly all attempts at biomarker development have relied on fixed tumor tissue or studies in plasma. Meanwhile, emerging functional approaches to study patient derived samples, such as organoid development and circulating tumor cell culture, lack features of the native tumor immune microenvironment and thus are limited in the ability to assess ex vivo anti-PD-1 response. We have developed a novel approach to study short-term ex vivo response to immune checkpoint blockade based upon short term culture of murine- and patient-derived organotypic tumor spheroids (MDOTS/PDOTS) in a 3-dimensional microfluidic system. Spheroids derived from fresh mouse and human tumor samples through partial collagenase digestion and filtration retain autologous tumor infiltrating immune cells, including PD-1 positive CD8 T lymphocytes. Using murine syngeneic mouse cancer models with known responsiveness or resistance to PD-1 blockade, we demonstrate the ability to recapitulate tumor killing ex vivo or lack thereof. Multiplexed cytokine profiling of conditioned media in this system further enables characterization of the cytokine and chemokine response to PD-1 and/or CTLA-4 blockade. We thus analyzed the secreted cytokine/chemokine response to PD-1 inhibition across a large panel of PDOTS, and observed pronounced induction of CCL19/CXCL13, which associated with % PD-1 positive CD8 T cells. This strategy further uncovered production of a class of myeloid attracting chemokines and cytokines in major proportion of samples, which clustered with the presence of plasmacytoid dendritic cells and myeloid derived suppressor cells. Importantly, the presence of this maladaptive cytokine/chemokine signature correlated with lack of response in the subset of patients that had been treated with PD-1 blockade. Together, these data demonstrate the ability to profile the functional response to tumor PD-1 blockade ex vivo and unveil a novel strategy to advance precision immuno-oncology. Citation Format: David A. Barbie, Russell Jenkins, Kwok-Kin Wong. Ex vivo profiling of PD-1 blockade using organotypic tumor spheroids [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 3972. doi:10.1158/1538-7445.AM2017-3972
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
hz发布了新的文献求助10
5秒前
精明尔柳完成签到,获得积分10
7秒前
24秒前
FashionBoy的应助被落润晓采纳,获得10
37秒前
阔达的碧彤完成签到,获得积分10
42秒前
53秒前
昏睡的碧菡完成签到,获得积分10
1分钟前
科研通AI6.4的应助被纯情的阁采纳,获得10
1分钟前
h11的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得30
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.4的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.4的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.4的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得100
1分钟前
1分钟前
所所的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.4的应助被纯情的阁采纳,获得10
1分钟前
华仔的应助被纯情的阁采纳,获得30
1分钟前
科研通AI6.4的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
1分钟前
赘婿的应助被纯情的阁采纳,获得30
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得30
1分钟前
科研通AI6.4的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得30
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
1分钟前
田様的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
1分钟前
1分钟前
hz完成签到 ,获得积分10
1分钟前
科研通AI6.4的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158770
求助须知:如何正确求助?哪些是违规求助? 9554476
关于积分的说明 21719316
捐赠科研通 7748357
什么是DOI,文献DOI怎么找? 3427080
关于科研通互助平台的介绍 2551971
邀请新用户注册赠送积分活动 2471354